Moderna
mRNA medicine pioneer — Spikevax COVID vaccine and expanding pipeline in flu, RSV, and cancer; proprietary LNP delivery and GMP mRNA manufacturing in Norwood, MA.
- Country
- United States
- Revenue
- $3.2B
- Employees
- ~5,000 emp
FDA GMP
GMP EU
Coverage
| CN | EU | US | |
|---|---|---|---|
| therapeutics-platforms | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Drug & vaccine development | therapeutics-platforms | High | → |
| mRNA platforms & LNP delivery | therapeutics-platforms | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.